18F-DOPA II - PET Imaging Optimization | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
18F-DOPA II - PET Imaging Optimization	Congenital Hyperinsulinism, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, Lewy body dementia, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Nutritional and Metabolic Diseases, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system cancer, central nervous system disorder, cognitive disorder, dementia, epithelial neoplasm, glucose metabolism disease, hyperinsulinism, hypoglycemia, metabolic disease, movement disorder, neoplasm, nervous system disorder, neuroblastoma, neurodegenerative disease, neuroendocrine neoplasm, neuroepithelial neoplasm, pancreas disorder, parkinsonian disorder, primitive neuroectodermal tumor, psychiatric disorder, synucleinopathy	Recruiting	Phase 3	2026-02-09		NCT04706910

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Alberta	249

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
WC Mackenzie Health Science Centre / University of Alberta Hospital	Edmonton	Canada	1